 Goldman Sachs Group Inc. boosted its stake in shares of Eidos Therapeutics Inc NASDAQ:EIDX by 39.4 in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission SEC. The firm owned 50,998 shares of the companys stock after purchasing an additional 14,404 shares during the ... 